Form 4 · Filed Jun 22, 2026, 09:23 PM UTC
NBP/NovaBridge Biosciences
Dennis Phillip Andrew — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | S | sell | 8,494 | $1 | $5,606 | 157,941 |
| Jun 17, 2026 | M | other | 23,695 | — | — | 166,435 |
| Jun 17, 2026 | M | other | 10,302 | — | — | 82,422 |
Source: SEC EDGAR raw filing ↗ · Accession 0002089237-26-000006